HOME > News Releases

News Releases

2015.04.24
R&D
PDF/179KB
Sumitomo Dainippon Pharma Makes a Follow-up Announcement on the Preliminary Findings from a Phase III Clinical Study (PASTEL Study) of Lurasidone, an Atypical Antipsychotic Agent, in the Treatment of Patients with Schizophrenia
2015.04.24
Corporate
PDF/130KB
Sumitomo Dainippon Pharma Revises Its Basic Policy on Internal Control System
2015.03.20
Corporate
PDF/41KB
Sumitomo Dainippon Pharma announces personnel changes
2015.03.03
Products
PDF/114KB
Toray Applies for Japanese Approval of Additional Indication of Pruritus Treatment REMITCH CAPSULES 2.5 µg and Notice Regarding Promotion Tie-up
2015.03.02
Corporate
PDF/119KB
Sumitomo Dainippon Pharma announces Organizational Realignment and Changes Related to Officers and Other Key Positions
2015.02.26
R&D
PDF/326KB
Sunovion Pharmaceuticals Inc. Announces Initiation of Phase 3 Clinical Trial Program for SUN-101/eFlow® (Glycopyrrolate) in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)
More News Releases

Page Top